Softgel Capsules Market
完整報告名稱與涵蓋範圍
Softgel Capsules Market Size, Share & Trends Analysis Report By Type (Gelatin-based/Animal-based, Non-Animal-Based), By Application (Antacid and Anti-Flatulent Preparation, Anti-Anemic Preparations), By End-use, By Region, And Segment Forecasts, 2026 - 2033
報告摘要
Softgel Capsules Market Summary
The global softgel capsules market size was valued at USD 8.5 billion in 2025 and is projected to grow from USD 9.1 billion in 2026 to USD 15.4 billion by 2033, at a CAGR of 7.9% from 2026 to 2033. North America dominated the market, accounting for the largest global share of 41.2% in 2025. The softgel capsules market is experiencing steady growth, supported by increasing demand from the pharmaceutical, nutraceutical, and over-the-counter healthcare industries.
Rising consumption of dietary supplements, preventive healthcare products, and specialty oral formulations continues to expand the use of softgel capsules across developed and emerging markets. Pharmaceutical manufacturers are increasing the use of softgel dosage forms for products requiring improved bioavailability, dose accuracy, and formulation stability, while nutraceutical companies are expanding product portfolios to address growing consumer interest in vitamins, minerals, omega-3 supplements, and herbal formulations.
Contract development and manufacturing organizations are also strengthening softgel manufacturing capacity as pharmaceutical and consumer health companies continue to outsource production. In addition, manufacturers are investing in advanced encapsulation technologies, vegetarian capsule materials, and production automation to improve manufacturing efficiency and meet changing regulatory and consumer requirements. Growth in e-commerce distribution, expanding healthcare access, and continued product innovation across pharmaceutical and consumer health categories are supporting the market's development across major regional markets.
Global Softgel Capsules Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global softgel capsules market report based on type, application, end-use, and region:
• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Gelatin-Based/Animal-Based
• Non-Animal-Based
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Antacid and Anti-Flatulent Preparation
• Anti-Anemic Preparations
• Anti-Inflammatory Drugs
• Antibiotic and Antibacterial Drugs
• Cough and Cold Preparations
• Health Supplement
• Vitamin and Dietary Supplement
• Pregnancy
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Pharmaceutical Companies
• Nutraceutical Companies
• Cosmeceutical Companies
• Contract Manufacturing Organization
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
o U.S.
o Canada
o Mexico
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Denmark
o Sweden
o Norway
• Asia Pacific
o Japan
o China
o India
o Australia
o South Korea
o Thailand
• Latin America
o Brazil
o Argentina
• Middle East & Africa
o South Africa
o Saudi Arabia
o UAE
o Kuwait
授權報價
| Single User License | $5,950 USD |
| Enterprise License | $6,950 USD |
| Corporate User License | $8,950 USD |
目錄 Table of Contents
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Application
1.2.3. End-use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Softgel Capsules Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
3.3.3. Pricing Analysis
Chapter 4. Softgel Capsules Market: Type Business Analysis
4.1. Type Market Share, 2025 & 2033
4.2. Type Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Type, 2021 to 2033 (USD Million)
4.4. Gelatin-Based/Animal-Based
4.4.1. Gelatin-Based/Animal-Based Market, 2021 - 2033 (USD Million)
4.5. Non-Animal-Based
4.5.1. Non-Animal-Based Market, 2021 - 2033 (USD Million)
Chapter 5. Softgel Capsules Market: Application Business Analysis
5.1. Application Market Share, 2025 & 2033
5.2. Application Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
5.4. Antacid and Anti-Flatulent Preparation
5.4.1. Antacid and Anti-Flatulent Preparation, 2021 - 2033 (USD Million)
5.5. Anti-Anemic Preparations
5.5.1. Anti-Anemic Preparations Market, 2021 - 2033 (USD Million)
5.6. Anti-Inflammatory Drugs
5.6.1. Anti-Inflammatory Drugs Market, 2021 - 2033 (USD Million)
5.7. Antibiotic and Antibacterial Drugs
5.7.1. Antibiotic and Antibacterial Drugs Market, 2021 - 2033 (USD Million)
5.8. Cough and Cold Preparations
5.8.1. Cough and Cold Preparations Market, 2021 - 2033 (USD Million)
5.9. Health Supplement
5.9.1. Health Supplement Market, 2021 - 2033 (USD Million)
5.10. Vitamin and Dietary Supplement
5.10.1. Vitamin and Dietary Supplement Market, 2021 - 2033 (USD Million)
5.11. Pregnancy
5.11.1. Pregnancy Market, 2021 - 2033 (USD Million)
Chapter 6. Softgel Capsules Market: End Use Business Analysis
6.1. End Use Market Share, 2025 & 2033
6.2. End-use Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by End-use, 2021 to 2033 (USD Million)
6.4. Pharmaceutical Companies
6.4.1. Pharmaceutical Companies Market, 2021 - 2033 (USD Million)
6.5. Nutraceutical Companies
6.5.1. Nutraceutical Companies Market, 2021 - 2033 (USD Million)
6.6. Cosmeceutical Companies
6.6.1. Cosmeceutical Companies Market, 2021 - 2033 (USD Million)
6.7. Contract Manufacturing Organization
6.7.1. Contract Manufacturing Organization Market, 2021 - 2033 (USD Million)
Chapter 7. Softgel Capsules Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2025 & 2033
7.2. Regional Market Dashboard
7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
7.4. North America
7.4.1. North America Softgel Capsules Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
7.4.2. U.S.
7.4.2.1. Key Country Dynamics
7.4.2.2. Target Disease Prevalence
7.4.2.3. Regulatory Framework
7.4.2.4. Reimbursement Framework
7.4.2.5. U.S. Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4.3. Canada
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Regulatory Framework
7.4.3.4. Reimbursement Framework
7.4.3.5. Canada Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4.4. Mexico
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Regulatory Framework
7.4.4.4. Reimbursement Framework
7.4.4.5. Mexico Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. Europe
7.5.1. Europe Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.2. UK
7.5.2.1. Key Country Dynamics
7.5.2.2. Target Disease Prevalence
7.5.2.3. Regulatory Framework
7.5.2.4. Reimbursement Framework
7.5.2.5. UK Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.3. Germany
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Regulatory Framework
7.5.3.4. Reimbursement Framework
7.5.3.5. Germany Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.4. France
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Regulatory Framework
7.5.4.4. Reimbursement Framework
7.5.4.5. France Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.5. Italy
7.5.5.1. Key Country Dynamics
7.5.5.2. Target Disease Prevalence
7.5.5.3. Regulatory Framework
7.5.5.4. Reimbursement Framework
7.5.5.5. Italy Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.6. Spain
7.5.6.1. Key Country Dynamics
7.5.6.2. Target Disease Prevalence
7.5.6.3. Regulatory Framework
7.5.6.4. Reimbursement Framework
7.5.6.5. Spain Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.7. Denmark
7.5.7.1. Key Country Dynamics
7.5.7.2. Target Disease Prevalence
7.5.7.3. Regulatory Framework
7.5.7.4. Reimbursement Framework
7.5.7.5. Denmark Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.8. Sweden
7.5.8.1. Key Country Dynamics
7.5.8.2. Target Disease Prevalence
7.5.8.3. Regulatory Framework
7.5.8.4. Reimbursement Framework
7.5.8.5. Sweden Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.9. Norway
7.5.9.1. Key Country Dynamics
7.5.9.2. Target Disease Prevalence
7.5.9.3. Regulatory Framework
7.5.9.4. Reimbursement Framework
7.5.9.5. Norway Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6.2. Japan
7.6.2.1. Key Country Dynamics
7.6.2.2. Target Disease Prevalence
7.6.2.3. Regulatory Framework
7.6.2.4. Reimbursement Framework
7.6.2.5. Japan Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6.3. China
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Regulatory Framework
7.6.3.4. Reimbursement Framework
7.6.3.5. China Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6.4. India
7.6.4.1. Key Country Dynamics
7.6.4.2. Target Disease Prevalence
7.6.4.3. Regulatory Framework
7.6.4.4. Reimbursement Framework
7.6.4.5. India Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6.5. Australia
7.6.5.1. Key Country Dynamics
7.6.5.2. Target Disease Prevalence
7.6.5.3. Regulatory Framework
7.6.5.4. Reimbursement Framework
7.6.5.5. Australia Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6.6. South Korea
7.6.6.1. Key Country Dynamics
7.6.6.2. Target Disease Prevalence
7.6.6.3. Regulatory Framework
7.6.6.4. Reimbursement Framework
7.6.6.5. South Korea Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6.7. Thailand
7.6.7.1. Key Country Dynamics
7.6.7.2. Target Disease Prevalence
7.6.7.3. Regulatory Framework
7.6.7.4. Reimbursement Framework
7.6.7.5. Thailand Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7. Latin America
7.7.1. Latin America Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Target Disease Prevalence
7.7.2.3. Regulatory Framework
7.7.2.4. Reimbursement Framework
7.7.2.5. Brazil Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7.3. Argentina
7.7.3.1. Key Country Dynamics
7.7.3.2. Target Disease Prevalence
7.7.3.3. Regulatory Framework
7.7.3.4. Reimbursement Framework
7.7.3.5. Argentina Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.8. Middle East and Africa
7.8.1. Middle East and Africa Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. Target Disease Prevalence
7.8.2.3. Regulatory Framework
7.8.2.4. Reimbursement Framework
7.8.2.5. South Africa Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Target Disease Prevalence
7.8.3.3. Regulatory Framework
7.8.3.4. Reimbursement Framework
7.8.3.5. Saudi Arabia Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. Target Disease Prevalence
7.8.4.3. Regulatory Framework
7.8.4.4. Reimbursement Framework
7.8.4.5. UAE Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key Country Dynamics
7.8.5.2. Target Disease Prevalence
7.8.5.3. Regulatory Framework
7.8.5.4. Reimbursement Framework
7.8.5.5. Kuwait Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Participant Overview
8.2. Company Market Position Analysis
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing
8.5.1. Fuji Capsule
8.5.1.1. Overview
8.5.1.2. Financial Performance
8.5.1.3. Product Benchmarking
8.5.1.4. Strategic Initiatives
8.5.2. Sirio Pharma Co., Ltd.
8.5.2.1. Overview
8.5.2.2. Financial Performance
8.5.2.3. Product Benchmarking
8.5.2.4. Strategic Initiatives
8.5.3. CAPTEK Softgel International Inc.
8.5.3.1. Overview
8.5.3.2. Financial Performance
8.5.3.3. Product Benchmarking
8.5.3.4. Strategic Initiatives
8.5.4. Thermo Fisher Scientific Inc.
8.5.4.1. Overview
8.5.4.2. Financial Performance
8.5.4.3. Product Benchmarking
8.5.4.4. Strategic Initiatives
8.5.5. EyePoint Pharmaceuticals, Inc.
8.5.5.1. Overview
8.5.5.2. Financial Performance
8.5.5.3. Product Benchmarking
8.5.5.4. Strategic Initiatives
8.5.6. Catalent, Inc.
8.5.6.1. Overview
8.5.6.2. Financial Performance
8.5.6.3. Product Benchmarking
8.5.6.4. Strategic Initiatives
8.5.7. EuroCaps
8.5.7.1. Overview
8.5.7.2. Financial Performance
8.5.7.3. Product Benchmarking
8.5.7.4. Strategic Initiatives
8.5.8. Aenova Group
8.5.8.1. Overview
8.5.8.2. Financial Performance
8.5.8.3. Product Benchmarking
8.5.8.4. Strategic Initiative
8.5.9. Lonza Capsules & Health Ingredients
8.5.9.1. Overview
8.5.9.2. Financial Performance
8.5.9.3. Product Benchmarking
8.5.9.4. Strategic Initiatives
8.5.10. ProCaps Laboratories, LLC
8.5.10.1. Overview
8.5.10.2. Financial Performance
8.5.10.3. Product Benchmarking
8.5.10.4. Strategic Initiatives
8.5.11. Soft Gel Technologies, Inc.
8.5.11.1. Overview
8.5.11.2. Financial Performance
8.5.11.3. Product Benchmarking
8.5.11.4. Strategic Initiatives
圖表清單 List of Tables & Figures
List of Tables
Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. Global Softgel capsules market, by region, 2021 - 2033 (USD Million)
Table 4. Global Softgel capsules market, by type, 2021 - 2033 (USD Million)
Table 5. Global Softgel capsules market, by application, 2021 - 2033 (USD Million)
Table 6. Global Softgel capsules market, by end-use, 2021 - 2033 (USD Million)
Table 7. North America Softgel capsules market, by country, 2021 - 2033 (USD Million)
Table 8. North America Softgel capsules market, by type, 2021 - 2033 (USD Million)
Table 9. North America Softgel capsules market, by application, 2021 - 2033 (USD Million)
Table 10. North America Softgel capsules market, by end-use, 2021 - 2033 (USD Million)
Table 11. U.S. Softgel capsules market, by type, 2021 - 2033 (USD Million)
Table 12. U.S. Softgel capsules market, by application, 2021 - 2033 (USD Million)
Table 13. U.S. Softgel capsules market, by end-use, 2021 - 2033 (USD Million)
Table 14. Canada Softgel capsules market, by type, 2021 - 2033 (USD Million)
Table 15. Canada Softgel capsules market, by application, 2021 - 2033 (USD Million)
Table 16. Canada Softgel capsules market, by end-use, 2021 - 2033 (USD Million)
Table 17. Mexico Softgel capsules market, by type, 2021 - 2033 (USD Million)
Table 18. Mexico Softgel capsules market, by application, 2021 - 2033 (USD Million)
Table 19. Mexico Softgel capsules market, by end-use, 2021 - 2033 (USD Million)
Table 20. Europe Softgel capsules market, by country, 2021 - 2033 (USD Million)
Table 21. Europe Softgel capsules market, by type, 2021 - 2033 (USD Million)
Table 22. Europe Softgel capsules market, by application, 2021 - 2033 (USD Million)
Table 23. Europe Softgel capsules market, by end-use, 2021 - 2033 (USD Million)
Table 24. UK Softgel capsules market, by type, 2021 - 2033 (USD Million)
Table 25. UK Softgel capsules market, by application, 2021 - 2033 (USD Million)
Table 26. UK Softgel capsules market, by end-use, 2021 - 2033 (USD Million)
Table 27. Germany Softgel capsules market, by type, 2021 - 2033 (USD Million)
Table 28. Germany Softgel capsules market, by application, 2021 - 2033 (USD Million)
Table 29. Germany Softgel capsules market, by end-use, 2021 - 2033 (USD Million)
Table 30. France Softgel capsules market, by type, 2021 - 2033 (USD Million)
Table 31. France Softgel capsules market, by application, 2021 - 2033 (USD Million)
Table 32. France Softgel capsules market, by end-use, 2021 - 2033 (USD Million)
Table 33. Italy Softgel capsules market, by type, 2021 - 2033 (USD Million)
Table 34. Italy Softgel capsules market, by application, 2021 - 2033 (USD Million)
Table 35. Italy Softgel capsules market, by end-use, 2021 - 2033 (USD Million)
Table 36. Spain Softgel capsules market, by type, 2021 - 2033 (USD Million)
Table 37. Spain Softgel capsules market, by application, 2021 - 2033 (USD Million)
Table 38. Spain Softgel capsules market, by end-use, 2021 - 2033 (USD Million)
Table 39. Norway Softgel capsules market, by type, 2021 - 2033 (USD Million)
Table 40. Norway Softgel capsules market, by application, 2021 - 2033 (USD Million)
Table 41. Norway Softgel capsules market, by end-use, 2021 - 2033 (USD Million)
Table 42. Denmark Softgel capsules market, by type, 2021 - 2033 (USD Million)
Table 43. Denmark Softgel capsules market, by application, 2021 - 2033 (USD Million)
Table 44. Denmark Softgel capsules market, by end-use, 2021 - 2033 (USD Million)
Table 45. Sweden Softgel capsules market, by type, 2021 - 2033 (USD Million)
Table 46. Sweden Softgel capsules market, by application, 2021 - 2033 (USD Million)
Table 47. Sweden Softgel capsules market, by end-use, 2021 - 2033 (USD Million)
Table 48. Asia Pacific Softgel capsules market, by country, 2021 - 2033 (USD Million)
Table 49. Asia Pacific Softgel capsules market, by type, 2021 - 2033 (USD Million)
Table 50. Asia Pacific Softgel capsules market, by application, 2021 - 2033 (USD Million)
Table 51. Asia Pacific Softgel capsules market, by end-use, 2021 - 2033 (USD Million)
Table 52. Japan Softgel capsules market, by type, 2021 - 2033 (USD Million)
Table 53. Japan Softgel capsules market, by application, 2021 - 2033 (USD Million)
Table 54. Japan Softgel capsules market, by end-use, 2021 - 2033 (USD Million)
Table 55. China Softgel capsules market, by type, 2021 - 2033 (USD Million)
Table 56. China Softgel capsules market, by application, 2021 - 2033 (USD Million)
Table 57. China Softgel capsules market, by end-use, 2021 - 2033 (USD Million)
Table 58. India Softgel capsules market, by type, 2021 - 2033 (USD Million)
Table 59. India Softgel capsules market, by application, 2021 - 2033 (USD Million)
Table 60. India Softgel capsules market, by end-use, 2021 - 2033 (USD Million)
Table 61. Australia Softgel capsules market, by type, 2021 - 2033 (USD Million)
Table 62. Australia Softgel capsules market, by application, 2021 - 2033 (USD Million)
Table 63. Australia Softgel capsules market, by end-use, 2021 - 2033 (USD Million)
Table 64. South Korea Softgel capsules market, by type, 2021 - 2033 (USD Million)
Table 65. South Korea Softgel capsules market, by application, 2021 - 2033 (USD Million)
Table 66. South Korea Softgel capsules market, by end-use, 2021 - 2033 (USD Million)
Table 67. Thailand Softgel capsules market, by type, 2021 - 2033 (USD Million)
Table 68. Thailand Softgel capsules market, by application, 2021 - 2033 (USD Million)
Table 69. Thailand Softgel capsules market, by end-use, 2021 - 2033 (USD Million)
Table 70. Latin America Softgel capsules market, by country, 2021 - 2033 (USD Million)
Table 71. Latin America Softgel capsules market, by type, 2021 - 2033 (USD Million)
Table 72. Latin America Softgel capsules market, by application, 2021 - 2033 (USD Million)
Table 73. Latin America Softgel capsules market, by end-use, 2021 - 2033 (USD Million)
Table 74. Brazil Softgel capsules market, by type, 2021 - 2033 (USD Million)
Table 75. Brazil Softgel capsules market, by application, 2021 - 2033 (USD Million)
Table 76. Brazil Softgel capsules market, by end-use, 2021 - 2033 (USD Million)
Table 77. Argentina Softgel capsules market, by type, 2021 - 2033 (USD Million)
Table 78. Argentina Softgel capsules market, by application, 2021 - 2033 (USD Million)
Table 79. Argentina Softgel capsules market, by end-use, 2021 - 2033 (USD Million)
Table 80. Middle East & Africa Softgel capsules market, by country, 2021 - 2033 (USD Million)
Table 81. Middle East & Africa Softgel capsules market, by type, 2021 - 2033 (USD Million)
Table 82. Middle East & Africa Softgel capsules market, by application, 2021 - 2033 (USD Million)
Table 83. Middle East & Africa Softgel capsules market, by end-use, 2021 - 2033 (USD Million)
Table 84. South Africa Softgel capsules market, by type, 2021 - 2033 (USD Million)
Table 85. South Africa Softgel capsules market, by application, 2021 - 2033 (USD Million)
Table 86. South Africa Softgel capsules market, by end-use, 2021 - 2033 (USD Million)
Table 87. Saudi Arabia Softgel capsules market, by type, 2021 - 2033 (USD Million)
Table 88. Saudi Arabia Softgel capsules market, by application, 2021 - 2033 (USD Million)
Table 89. Saudi Arabia Softgel capsules market, by end-use, 2021 - 2033 (USD Million)
Table 90. UAE Softgel capsules market, by type, 2021 - 2033 (USD Million)
Table 91. UAE Softgel capsules market, by application, 2021 - 2033 (USD Million)
Table 92. UAE Softgel capsules market, by end-use, 2021 - 2033 (USD Million)
Table 93. Kuwait Softgel capsules market, by type, 2021 - 2033 (USD Million)
Table 94. Kuwait Softgel capsules market, by application, 2021 - 2033 (USD Million)
Table 95. Kuwait Softgel capsules market, by end-use, 2021 - 2033 (USD Million)
List of Figures
Fig. 1 Softgel Capsules Market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Competitive landscape
Fig. 10 Softgel capsules market dynamics
Fig. 11 Softgel capsules market: Porter’s five forces analysis
Fig. 12 Softgel capsules market: PESTLE analysis
Fig. 13 Type market, 2021 - 2033 (USD Million)
Fig. 14 Gelatin-based/animal-based market, 2021 - 2033 (USD Million)
Fig. 15 Non-animal-based market, 2021 - 2033 (USD Million)
Fig. 16 Application market, 2021 - 2033 (USD Million)
Fig. 17 Antacid and anti-flatulent preparation market, 2021 - 2033 (USD Million)
Fig. 18 Anti-anemic preparations market, 2021 - 2033 (USD Million)
Fig. 19 Anti-inflammatory drugs market, 2021 - 2033 (USD Million)
Fig. 20 Antibiotic and antibacterial drugs market, 2021 - 2033 (USD Million)
Fig. 21 Cough and cold preparations market, 2021 - 2033 (USD Million)
Fig. 22 Health supplement market, 2021 - 2033 (USD Million)
Fig. 23 Vitamin and dietary supplement market, 2021 - 2033 (USD Million)
Fig. 24 Pregnancy market, 2021 - 2033 (USD Million)
Fig. 25 End-use market, 2021 - 2033 (USD Million)
Fig. 26 Pharmaceutical companies market, 2021 - 2033 (USD Million)
Fig. 27 Nutraceutical companies market, 2021 - 2033 (USD Million)
Fig. 28 Cosmeceutical companies market, 2021 - 2033 (USD Million)
Fig. 29 Contract manufacturing organization market, 2021 - 2033 (USD Million)
Fig. 30 Softgel capsules market revenue, by region
Fig. 31 Regional marketplace: Key takeaways
Fig. 32 North America Softgel capsules market, 2021 - 2033 (USD Million)
Fig. 33 U.S. country dynamics
Fig. 34 U.S. Softgel capsules market, 2021 - 2033 (USD Million)
Fig. 35 Canada country dynamics
Fig. 36 Canada Softgel capsules market, 2021 - 2033 (USD Million)
Fig. 37 Mexico country dynamics
Fig. 38 Mexico Softgel capsules market, 2021 - 2033 (USD Million)
Fig. 39 Europe Softgel capsules market, 2021 - 2033 (USD Million)
Fig. 40 UK country dynamics
Fig. 41 UK Softgel capsules market, 2021 - 2033 (USD Million)
Fig. 42 Germany country dynamics
Fig. 43 Germany Softgel capsules market, 2021 - 2033 (USD Million)
Fig. 44 France country dynamics
Fig. 45 France Softgel capsules market, 2021 - 2033 (USD Million)
Fig. 46 Italy country dynamics
Fig. 47 Italy Softgel capsules market, 2021 - 2033 (USD Million)
Fig. 48 Spain country dynamics
Fig. 49 Spain Softgel capsules market, 2021 - 2033 (USD Million)
Fig. 50 Norway country dynamics
Fig. 51 Norway Softgel capsules market, 2021 - 2033 (USD Million)
Fig. 52 Sweden country dynamics
Fig. 53 Sweden Softgel capsules market, 2021 - 2033 (USD Million)
Fig. 54 Denmark country dynamics
Fig. 55 Denmark Softgel capsules market, 2021 - 2033 (USD Million)
Fig. 56 Asia Pacific Softgel capsules market, 2021 - 2033 (USD Million)
Fig. 57 Japan country dynamics
Fig. 58 Japan Softgel capsules market, 2021 - 2033 (USD Million)
Fig. 59 China country dynamics
Fig. 60 China Softgel capsules market, 2021 - 2033 (USD Million)
Fig. 61 India country dynamics
Fig. 62 India Softgel capsules market, 2021 - 2033 (USD Million)
Fig. 63 Australia country dynamics
Fig. 64 Australia Softgel capsules market, 2021 - 2033 (USD Million)
Fig. 65 South Korea country dynamics
Fig. 66 South Korea Softgel capsules market, 2021 - 2033 (USD Million)
Fig. 67 Thailand country dynamics
Fig. 68 Thailand Softgel capsules market, 2021 - 2033 (USD Million)
Fig. 69 Latin America Softgel capsules market, 2021 - 2033 (USD Million)
Fig. 70 Brazil country dynamics
Fig. 71 Brazil Softgel capsules market, 2021 - 2033 (USD Million)
Fig. 72 Argentina country dynamics
Fig. 73 Argentina Softgel capsules market, 2021 - 2033 (USD Million)
Fig. 74 MEA Softgel capsules market, 2021 - 2033 (USD Million)
Fig. 75 South Africa country dynamics
Fig. 76 South Africa Softgel capsules market, 2021 - 2033 (USD Million)
Fig. 77 Saudi Arabia country dynamics
Fig. 78 Saudi Arabia Softgel capsules market, 2021 - 2033 (USD Million)
Fig. 79 UAE country dynamics
Fig. 80 UAE Softgel capsules market, 2021 - 2033 (USD Million)
Fig. 81 Kuwait country dynamics
Fig. 82 Kuwait Softgel capsules market, 2021 - 2033 (USD Million)
Fig. 83 Company categorization
Fig. 84 Company market position analysis
Fig. 85 Strategic framework
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Grand View Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們